Atrium Therapeutics, Inc.

NASDAQ:RNA

Biotechnology

Healthcare
$6.64 +1.28%

+$0.16 today

Market cap
$143.23M
Beta
0.42
P/E (TTM)
-3.3
EPS (TTM)
-$3.78
52W Low $11.40High $16.77

Volume 0.22M

Average 0.35M

RNA Retained Earnings

Cumulative profits kept in the business rather than paid out as dividends.

Atrium Therapeutics, Inc.NASDAQ: RNA

Retained Earnings · Q1 FY2026 · quarter ended Mar 2026

Retained earnings of $12.13M in Q1 FY2026

Q1 FY2026 retained earnings was $12.13M.

Context

  • Retained earnings amounted to 4.1% of total assets at the end of Q1 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$12.13M— QoQ
Last fiscal yearDec 2025
$0— YoY
Retained Earnings past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Retained Earnings history

USD · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Retained Earnings vs competitors

How RNA compares with its peers on the latest reported figures

No competitor Retained Earnings figures are available to compare.

Atrium Therapeutics, Inc.

NASDAQ:RNA

Intrinsic Alpha fair value

Locked

Current Price

$6.64

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.